Parkman Healthcare Partners’s Societal CDMO, Inc. Common Stock SCTL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-671,817
Closed -$1.21M 89
2022
Q1
$1.21M Buy
671,817
+26,142
+4% +$45.3K 0.35% 62
2021
Q4
$1.1M Sell
645,675
-125,158
-16% -$214K 0.24% 73
2021
Q3
$1.59M Hold
770,833
0.4% 58
2021
Q2
$1.78M Buy
770,833
+168,866
+28% +$429K 0.39% 63
2021
Q1
$1.68M Buy
+601,967
New +$2.16M 0.39% 60

Other funds holding SCTL

Parkman Healthcare Partners's SCTL Position: Q2 2022 in Review

Parkman Healthcare Partners sold out of Societal CDMO, Inc. Common Stock (SCTL) in Q2 2022, closing a stake of 671,817 shares — an estimated $1.21M sold.

Parkman Healthcare Partners first reported a position in SCTL in Q1 2021 and held it in 5 quarters. The position peaked at $1.78M in Q2 2021. 45 funds tracked by Wall St. Rank hold SCTL as of Q2 2022.

  • Parkman Healthcare Partners reported no remaining Societal CDMO, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Parkman Healthcare Partners sold 671,817 Societal CDMO, Inc. Common Stock shares in Q2 2022, an estimated $1.21M.
  • Parkman Healthcare Partners first reported a position in Societal CDMO, Inc. Common Stock in Q1 2021 and held it in 5 quarters.
  • Parkman Healthcare Partners's Societal CDMO, Inc. Common Stock position peaked at $1.78M in Q2 2021.
  • 45 funds tracked by Wall St. Rank held Societal CDMO, Inc. Common Stock as of Q2 2022.

Based on Parkman Healthcare Partners's 13F filing for Q2 2022, filed 12 Aug 2022.